Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
47 studies found for:    Open Studies | "Adenoviridae Infections"
Show Display Options
Rank Status Study
21 Recruiting Safety Study of a Disrupted Adenovirus (Ad) Serotype Cocaine Vaccine for Cocaine-dependent Individuals
Condition: Cocaine Dependence
Interventions: Biological: dAd5GNE Vaccine;   Biological: Placebo
22 Recruiting Anti-virus Treatment Following Bone Marrow Transplant
Conditions: Allogeneic Stem Cell Transplant;   Viral Infection;   Viral Reactivation
Intervention: Biological: Viral specific CTL Infusion
23 Recruiting Multivirus-specific T Cells for the Treatment of Virus Infections After Stem Cell Transplant
Condition: Infection
Intervention: Biological: Multivirus Specific T cells
24 Recruiting A Study to Assess Safety and Feasibility of Direct Infusions of Donor-derived Virus-specific T-cells in Recipients of Hematopoietic Stem Cell Transplantation With Post-transplant Viral Infections Using the Cytokine Capture System®
Conditions: Adenovirus Infection;   EBV;   Cytomegalovirus Infections;   Cytokine Capture System;   Allogenic Disease
Intervention: Biological: IFN-γ positive selected T-cells
25 Recruiting DNX-2401 With Interferon Gamma (IFN-γ) for Recurrent Glioblastoma or Gliosarcoma Brain Tumors
Condition: Glioblastoma or Gliosarcoma
Interventions: Drug: Single intratumoral injection of DNX-2401;   Drug: Interferon-gamma
26 Not yet recruiting Ad-HGF Treatment for Myocardial Infarction
Condition: Myocardial Infarction
Interventions: Drug: Ad-HGF;   Other: 0.9% NaCl
27 Recruiting Multivirus-specific Cytotoxic T Lymphocytes (mCTL)
Condition: Refractory Viral Infections
Intervention: Biological: mCTLs
28 Recruiting Allogeneic Virus-specific T Cell Lines (VSTs)
Condition: Viral Infections After HSCT
Intervention: Biological: VSTs
29 Recruiting Registry on Salvage Antiviral Treatment for Patients Experiencing ADV and / or CMV Reactivation Post Allogeneic HSCT
Condition: Infectious Complications Following HSCT
Intervention: Other: antiviral therapies for CMV and/or ADV
30 Recruiting Gene Therapy Study in Severe Haemophilia A Patients
Condition: Severe Haemophilia A
Intervention: Genetic: BMN 270
31 Recruiting Phase I Dose Escalation Study of Intravenous VCN-01 With or Without Gemcitabine and Abraxane® in Patients With Advanced Solid Tumors
Conditions: Locally Advanced Solid Tumors;   Metastatic Solid Tumors;   Pancreatic Adenocarcinoma
Interventions: Genetic: VCN-01;   Drug: Gemcitabine;   Drug: Abraxane®
32 Not yet recruiting Oncolytic MG1-MAGEA3 With Ad-MAGEA3 Vaccine in Combination With Pembrolizumab for Non-Small Cell Lung Cancer Patients
Condition: Non-Small Cell Lung Cancer
Interventions: Biological: Ad-MAGEA3;   Biological: MG1-MAGEA3;   Biological: Pembrolizumab
33 Recruiting Safety and Efficacy Study of Vaccine Schedule With Ad26.Mos.HIV and MVA-Mosaic in Human Immunodeficiency Virus (HIV)-Infected Adults
Condition: Human Immunodeficiency Virus (HIV)
Interventions: Biological: Ad26.Mos.HIV;   Biological: MVA-Mosaic;   Drug: Placebo
34 Recruiting GVAX vs. Placebo for MDS/AML After Allo HSCT
Conditions: Myelodysplastic Syndrome;   Acute Myeloid Leukemia
Interventions: Biological: GVAX;   Biological: Placebo Vaccine;   Procedure: Allogeneic Hematopoietic Stem Cell Transplant;   Drug: Busulfan;   Drug: Fludarabine;   Drug: Tacrolimus;   Drug: Methotrexate
35 Not yet recruiting Administration of AdVEGF-All6A+ to Myocardium of Individuals With Diffuse CAD Via Minimally Invasive Surgery
Condition: Coronary Artery Disease
Interventions: Biological: AdVEGF-All6A+;   Biological: AdNull
36 Recruiting Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care
Conditions: Infection;   Hypertension;   Pain;   Reflux;   Edema;   Hyperlipidemia;   Hypotension;   Hypercholesterolemia;   Sedation;   Anxiolysis;   Benzodiazepine Withdrawal;   Bipolar Disorder;   Autistic Disorder;   Schizophrenia;   Influenza Treatment or Prophylaxis;   Acute Decompensated Heart Failure;   Stable Angina;   Life-threatening Fungal Infections;   Nosocomial Pneumonia;   Community Acquired Pneumonia;   Acute Bacterial Exacerbation of Chronic Bronchitis;   Complicated Skin and Skin Structure Infections;   Uncomplicated Skin and Skin Structure Infections;   Chronic Bacterial Prostatitis;   Complicated Urinary Tract Infections;   Acute Pyelonephritis;   Uncomplicated Urinary Tract Infections;   Inhalational Anthrax (Post-Exposure);   Infantile Hemangioma;   Withdrawal;   Inflammation;   Bacterial Septicemia;   Cytomegalovirus Retinitis;   Herpes Simplex Virus;   Adenovirus;   Brain Swelling;   Airway Swelling;   Adrenal Insufficiency;   Anxiety;   Nausea;   Vomiting;   Convulsions;   Muscle Spasms;   Seizures;   Epilepsy;   Bartonellosis;   Brucellosis;   Cholera;   Plague;   Psittacosis;   Q Fever;   Relapsing Fever;   Rocky Mountain Spotted Fever;   Trachoma;   Tularemia;   Typhus Fever;   Bronchospasm;   Cardiac Arrest;   Hypersensitivity Reaction;   Cyanide Poisoning;   Acute Bacterial Sinusitis;   Bacterial Meningitis;   Sepsis;   Gastroparesis;   Opioid Addiction;   Migraines;   Headaches
Intervention: Drug: The POPS study is collecting PK data on children prescribed the following drugs of interest per standard of care:
37 Recruiting Study of Safety and Immunogenicity of HIV Vaccines in Healthy Volunteers
Conditions: Healthy Volunteer;   HIV Vaccine
Interventions: Biological: Ad4-mgag;   Biological: Ad4-EnvC150
38 Recruiting E10A for the Treatment of Squamous Cell Carcinoma of the Head and Neck
Condition: Head and Neck Neoplasms
Interventions: Drug: Endostatins;   Drug: Paclitaxel injection;   Drug: Cisplatin injection
39 Recruiting Safety and Tolerability Clinical Trial of Different Doses of the Immunotherapeutic Drug Mobilan (M-VM3) and Placebo in Patients With Prostate Cancer
Condition: Prostate Cancer
Interventions: Drug: Mobilan (M-VM3);   Drug: Placebo
40 Recruiting A Multicenter Randomized Double-blind Placebo-controlled Pilot Study of Safety, Pharmacodynamics and Efficacy of Different Treatments of Immunotherapeutic Drug Mobilan (M-VM3) in Patients With Diagnosed Prostate Cancer
Condition: Prostate Cancer
Interventions: Drug: Mobilan (M-VM3);   Drug: Placebo

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-47) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.